|Application ||WB, E|
|Other Accession||Q80W54, NP_005848.2|
|Calculated MW||54813 Da|
|Antigen Region||404-433 aa|
|Other Names||CAAX prenyl protease 1 homolog, Farnesylated proteins-converting enzyme 1, FACE-1, Prenyl protein-specific endoprotease 1, Zinc metalloproteinase Ste24 homolog, ZMPSTE24, FACE1, STE24|
|Target/Specificity||This ZMPSTE24 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 404-433 amino acids from the C-terminal region of human ZMPSTE24.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||ZMPSTE24 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Proteolytically removes the C-terminal three residues of farnesylated proteins. Acts on lamin A/C.|
|Cellular Location||Endoplasmic reticulum membrane; Multi-pass membrane protein. Nucleus inner membrane; Multi-pass membrane protein|
|Tissue Location||Widely expressed. High levels in kidney, prostate, testis and ovary|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a member of the peptidase M48A family. The encoded protein is a zinc metalloproteinase involved in the two step post-translational proteolytic cleavage of carboxy terminal residues of farnesylated prelamin A to form mature lamin A. Mutations in this gene have been associated with mandibuloacral dysplasia and restrictive dermopathy.
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)
Miner, J.H. Am. J. Med. Genet. A 152A (8), 2140-2141 (2010) :
Smigiel, R., et al. Am. J. Med. Genet. A 152A (2), 447-452 (2010) :
Fontaine-Bisson, B., et al. J. Mol. Med. 88(2):193-201(2010)
Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.